Skip to main content
OpenTrials

Clinical trial condition

Advanced Solid Tumours

Explore clinical trials studying Advanced Solid Tumours. Study availability and eligibility vary by location and protocol.

34 public trials 7 recruiting studies
Refine in advanced search Browse all conditions

Advanced Solid Tumours trial results

Recruiting

A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer

NCT06380816

Conditions
Adnexal Diseases, Advanced Solid Tumours, Breast Diseases, +53 more
Locations
  • Guy's Hopsital London, United Kingdom
  • The Christie NHS Foundation Trust Manchester, United Kingdom
  • The Newcastle upon Tyne Hospitals NHS Foundation Trust Newcastle upon Tyne, United Kingdom
  • University Hospital Southampton NHS Foundation Trust Southampton, United Kingdom
View Trial Details
Recruiting

A Study of EBC-129 in Advanced Solid Tumours

NCT05701527

Conditions
Advanced Solid Tumours
Locations
  • University of Colorado Hospital (UCH) - University of Colorado Cancer Center (UCCC) - Neuroendocrine Tumor Center Aurora, Colorado, United States
  • UT MD Anderson Cancer Center Houston, Texas, United States
  • National University Hospital - Medical Oncology Singapore, South West
  • National Cancer Centre Singapore Singapore, South West
View Trial Details
Recruiting

First in Human Study of SIM0610 in Solid Tumors

NCT07348211

Conditions
Adenocarcinoma, Advanced Solid Tumours, Bronchial Neoplasms, +31 more
Locations
  • Chongqing Cancer Hospital Chongqing, Chongqing Municipality, China
  • Harbin Medical University Cancer Hospital Harbin, Heilongjiang, China
  • the First Hospital of China Medical University Shenyang, Liaoning, China
  • The Affiliated Cancer Hospital of Shandong First Medical University& Shan Dong Cancer Hospital Jinan, Shandong, China
View Trial Details
Recruiting

A Study of LM-168 as a Single Agent or in Combination With Toripalimab in Subjects With Advanced Solid Tumours

NCT06868199

Conditions
Advanced Solid Tumours
Locations
  • Macquarie University Ryde, New South Wales, Australia
  • MUPharm Pty Limited trading as Macquarie University Hospital Parmarcy Ryde, New South Wales, Australia
  • Cancer Care Wollongong Pty Limited Wollongong, New South Wales, Australia
  • Bayview Health-Investigational Drug Services Perth, Western Australia, Australia
View Trial Details
Completed

A Study Investigating DNA-damage Response Agents in Molecularly Altered Advanced Cancer

NCT04564027

Conditions
Advanced Solid Tumours, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +9 more
Locations
  • Research Site Duarte, California, United States
  • Research Site Los Angeles, California, United States
  • Research Site San Francisco, California, United States
  • Research Site Tampa, Florida, United States
View all 18 locations
View Trial Details

Related conditions